• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在发育过程中,fms样酪氨酸激酶4基因的表达局限于淋巴管内皮细胞。

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

作者信息

Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh V W, Fang G H, Dumont D, Breitman M, Alitalo K

机构信息

Molecular/Cancer Biology Laboratory, University of Helsinki, Finland.

出版信息

Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70. doi: 10.1073/pnas.92.8.3566.

DOI:10.1073/pnas.92.8.3566
PMID:7724599
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC42208/
Abstract

We have recently cloned the human fms-like tyrosine kinase 4 gene FLT4, whose protein product is related to two vascular endothelial growth factor receptors FLT1 and KDR/FLK1. Here the expression of FLT4 has been analyzed by in situ hybridization during mouse embryogenesis and in adult human tissues. The FLT4 mRNA signals first became detectable in the angioblasts of head mesenchyme, the cardinal vein, and extraembryonally in the allantois of 8.5-day postcoitus (p.c.) embryos. In 12.5-day p.c. embryos, the FLT4 signal decorated developing venous and presumptive lymphatic endothelia, but arterial endothelia were negative. During later stages of development, FLT4 mRNA became restricted to vascular plexuses devoid of red cells, representing developing lymphatic vessels. Only the lymphatic endothelia and some high endothelial venules expressed FLT4 mRNA in adult human tissues. Increased expression occurred in lymphatic sinuses in metastatic lymph nodes and in lymphangioma. Our results suggest that FLT4 is a marker for lymphatic vessels and some high endothelial venules in human adult tissues. They also support the theory on the venous origin of lymphatic vessels.

摘要

我们最近克隆了人类fms样酪氨酸激酶4基因FLT4,其蛋白质产物与两种血管内皮生长因子受体FLT1和KDR/FLK1相关。在此,我们通过原位杂交分析了FLT4在小鼠胚胎发育过程中和成人组织中的表达情况。FLT4 mRNA信号最早在8.5天交配后(p.c.)胚胎头部间充质、主静脉的成血管细胞以及胚外尿囊中被检测到。在12.5天p.c.胚胎中,FLT4信号标记了发育中的静脉和假定的淋巴管内皮,但动脉内皮为阴性。在发育后期,FLT4 mRNA局限于不含红细胞的血管丛,代表发育中的淋巴管。在成人组织中,只有淋巴管内皮和一些高内皮微静脉表达FLT4 mRNA。在转移性淋巴结的淋巴窦和淋巴管瘤中表达增加。我们的结果表明,FLT4是成人组织中淋巴管和一些高内皮微静脉的标志物。它们也支持淋巴管起源于静脉的理论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/09752472bb50/pnas01492-0502-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/f65482132237/pnas01492-0499-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/1e08eb49ea56/pnas01492-0500-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/dfa0abd116b3/pnas01492-0500-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/ac46e7e60a52/pnas01492-0501-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/527e5438350a/pnas01492-0501-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/26e27349493b/pnas01492-0501-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/09752472bb50/pnas01492-0502-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/f65482132237/pnas01492-0499-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/1e08eb49ea56/pnas01492-0500-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/dfa0abd116b3/pnas01492-0500-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/ac46e7e60a52/pnas01492-0501-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/527e5438350a/pnas01492-0501-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/26e27349493b/pnas01492-0501-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/42208/09752472bb50/pnas01492-0502-a.jpg

相似文献

1
Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.在发育过程中,fms样酪氨酸激酶4基因的表达局限于淋巴管内皮细胞。
Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3566-70. doi: 10.1073/pnas.92.8.3566.
2
Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.血管内皮生长因子C受体VEGFR-3在皮肤淋巴管内皮及血管肿瘤中的表达。
Am J Pathol. 1998 Aug;153(2):395-403. doi: 10.1016/S0002-9440(10)65583-6.
3
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.一种新型血管内皮生长因子VEGF-C,是Flt4(血管内皮生长因子受体-3)和KDR(血管内皮生长因子受体-2)受体酪氨酸激酶的配体。
EMBO J. 1996 Jan 15;15(2):290-98.
4
Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase.
Oncogene. 1995 Mar 2;10(5):973-84.
5
Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.血管内皮生长因子相关蛋白:酪氨酸激酶受体Flt4的配体及特异性激活剂。
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1988-92. doi: 10.1073/pnas.93.5.1988.
6
FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
Cancer Res. 1992 Oct 15;52(20):5738-43.
7
Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.FLT4的信号传导特性,一种与两种血管内皮生长因子受体相关的经蛋白水解加工的受体酪氨酸激酶。
Oncogene. 1994 Dec;9(12):3545-55.
8
Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.血管内皮生长因子C表达在胃癌淋巴结转移发生中的作用
Clin Cancer Res. 1999 Jul;5(7):1823-9.
9
Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
Oncogene. 1993 Nov;8(11):2931-7.
10
Characterization of murine Flt4 ligand/VEGF-C.小鼠Flt4配体/VEGF-C的特性分析
Oncogene. 1997 Jul 31;15(5):613-8. doi: 10.1038/sj.onc.1201191.

引用本文的文献

1
Limited Proteolysis as a Regulator of Lymphatic Vessel Function and Architecture.有限蛋白水解作为淋巴管功能和结构的调节因子
Int J Mol Sci. 2025 Jul 24;26(15):7144. doi: 10.3390/ijms26157144.
2
New approaches to overcome radioresistance in glioblastoma: mechanisms, targets and role of innovative therapies, new particles and non-photon radiotherapy in 2024. A systematic review.2024年克服胶质母细胞瘤放射抗性的新方法:创新疗法、新粒子及非光子放疗的机制、靶点和作用。系统评价
Rep Pract Oncol Radiother. 2025 Jun 7;30(2):269-281. doi: 10.5603/rpor.105654. eCollection 2025.
3
Lymphatic complication in open venous harvesting versus endoscopic venous harvesting: a systematic review and meta-analysis.

本文引用的文献

1
Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis.成纤维细胞生长因子受体3基因在小鼠器官发生过程中的独特表达模式。
Dev Biol. 1993 Feb;155(2):423-30. doi: 10.1006/dbio.1993.1040.
2
Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system.Tie-1和Tie-2定义了另一类在早期胚胎血管系统中表达的假定受体酪氨酸激酶基因。
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9355-8. doi: 10.1073/pnas.90.20.9355.
3
Molecular cloning of murine FLT and FLT4.小鼠FLT和FLT4的分子克隆
开放静脉采集与内镜静脉采集的淋巴并发症:一项系统评价和荟萃分析。
Gen Thorac Cardiovasc Surg. 2025 May;73(5):297-311. doi: 10.1007/s11748-025-02126-1. Epub 2025 Feb 17.
4
Lymphangiomas with the presence of erythrocytes in mesenteric lymph nodes of Wistar Hannover rats.在Wistar Hannover大鼠肠系膜淋巴结中存在红细胞的淋巴管瘤。
J Toxicol Pathol. 2025 Jan;38(1):37-42. doi: 10.1293/tox.2024-0007. Epub 2024 Sep 13.
5
The Transcription Factor SOX18 Inhibitor Small Molecule 4 Is a Potential Treatment of Cancer-Induced Lymphatic Metastasis and Lymphangiosarcoma.转录因子SOX18抑制剂小分子4是癌症诱导的淋巴转移和淋巴管肉瘤的潜在治疗方法。
Cancer Rep (Hoboken). 2025 Jan;8(1):e70110. doi: 10.1002/cnr2.70110.
6
Aging-induced changes in lymphatic muscle cell transcriptomes are associated with reduced pumping of peripheral collecting lymphatic vessels in mice.衰老引起的淋巴管平滑肌细胞转录组变化与小鼠外周集合淋巴管泵血功能降低有关。
Dev Cell. 2025 Apr 7;60(7):1118-1133.e5. doi: 10.1016/j.devcel.2024.12.010. Epub 2024 Dec 27.
7
Advances in molecular imaging and targeted therapeutics for lymph node metastasis in cancer: a comprehensive review.癌症淋巴结转移的分子成像与靶向治疗进展:综述
J Nanobiotechnology. 2024 Dec 19;22(1):783. doi: 10.1186/s12951-024-02940-4.
8
Molecular Characterization and Interaction between Human VEGF-D and VEGFR-3.人血管内皮生长因子-D(VEGF-D)与血管内皮生长因子受体-3(VEGFR-3)之间的分子特征及相互作用
J Microbiol Biotechnol. 2024 Dec 28;34(12):2627-2636. doi: 10.4014/jmb.2409.09060. Epub 2024 Nov 20.
9
Molecules That Have Rarely Been Studied in Lymphatic Endothelial Cells.鲜有研究的淋巴管内皮细胞分子。
Int J Mol Sci. 2024 Nov 14;25(22):12226. doi: 10.3390/ijms252212226.
10
VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia-Brief Report.肾祖细胞中VEGFC过表达是肾淋巴管扩张症的模型——简要报告
Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):104-112. doi: 10.1161/ATVBAHA.124.319743. Epub 2024 Nov 14.
Oncogene. 1993 Aug;8(8):2293-8.
4
The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells.相关的FLT4、FLT1和KDR受体酪氨酸激酶在人胎儿内皮细胞中呈现出不同的表达模式。
J Exp Med. 1993 Dec 1;178(6):2077-88. doi: 10.1084/jem.178.6.2077.
5
Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.FLT4的信号传导特性,一种与两种血管内皮生长因子受体相关的经蛋白水解加工的受体酪氨酸激酶。
Oncogene. 1994 Dec;9(12):3545-55.
6
Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
Oncogene. 1993 Nov;8(11):2931-7.
7
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.高亲和力的血管内皮生长因子结合及发育表达表明Flk-1是血管发生和血管生成的主要调节因子。
Cell. 1993 Mar 26;72(6):835-46. doi: 10.1016/0092-8674(93)90573-9.
8
The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis.小鼠系受体酪氨酸激酶基因:胚胎血管生成过程中的表达
Oncogene. 1994 Feb;9(2):395-403.
9
Endothelial proliferation in tumours and normal tissues: continuous labelling studies.肿瘤与正常组织中的内皮细胞增殖:连续标记研究
Br J Cancer. 1984 Apr;49(4):405-13. doi: 10.1038/bjc.1984.66.
10
Vasculogenesis in the chick embryo. An ultrastructural study.鸡胚中的血管生成。一项超微结构研究。
Am J Anat. 1971 Apr;130(4):441-60. doi: 10.1002/aja.1001300406.